BE0043-5MG
| InVivoMab anti-mouse IL-2
| 5 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0033-2-25MG
| InVivoMab anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0016-2-5MG
| InVivoMab anti-mouse CD40
| 5 mg
| BioXCell
| in vivo CD40 activation, in vitro B cell stimulati
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0083-25MG
| InVivoMab mouse IgG1 isotype control
| 25 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
BE0015-1-50MG
| InVivoMab anti-mouse CD28
| 50 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, in vivo CD
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0004-1-1MG
| InVivoMab anti-mouse CD8?
| 1 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0001-1FAB 5MG
| InVivoMab anti-mouse CD3? F(ab')2 fragment
| 5 mg
| BioXCell
| in vivo T cell depletion
|
| Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0023-100MG
| InVivoMab anti-human CD71
| 100 mg
| BioXCell
| Flow cytometry, Immunohistochemistry (frozen), Imm
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0035-5MG
| InVivoMab anti-mouse MAdCAM-1
| 5 mg
| BioXCell
| in vivo MAdCAM-1 neutralization, Immunofluorescenc
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0050-100MG
| InVivoMab anti-mouse IL-10R (CD210)
| 100 mg
| BioXCell
| in vivo blocking of IL-10/IL-10R signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0006-5MG
| InVivoMab anti-mouse LFA-1? (CD11a)
| 5 mg
| BioXCell
| in vivo LFA-1 neutralization, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0045-25MG
| InVivoMab anti-mouse IL-4
| 25 mg
| BioXCell
| in vitro IL-4 neutralization, in vivo IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0003-2-100MG
| InVivoMab anti-human CD4
| 100 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, in vivo CD
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0005-50MG
| InVivoMab anti-human LFA-1? (CD11a)
| 50 mg
| BioXCell
| in vitro LFA-1 neutralization
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0077-25MG
| InVivoMab anti-mouse MHC Class I (H-2)
| 25 mg
| BioXCell
| ex vivo blocking of MHC I–dependent interactions,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0021-25MG
| InVivoMab anti-mouse L-Selectin (CD62L)
| 25 mg
| BioXCell
| In vivo CD62L neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0077-50MG
| InVivoMab anti-mouse MHC Class I (H-2)
| 50 mg
| BioXCell
| ex vivo blocking of MHC I–dependent interactions,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0059-50MG
| InVivoMab anti-mouse ICOS
| 50 mg
| BioXCell
| in vivo blocking of ICOS/ICOSL signaling, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0005-25MG
| InVivoMab anti-human LFA-1? (CD11a)
| 25 mg
| BioXCell
| in vitro LFA-1 neutralization
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0051-50MG
| InVivoMab anti-mouse IL-12 p40
| 50 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0026-1MG
| InVivoMab anti-mouse CD103
| 1 mg
| BioXCell
| In vivo CD103 neutralization, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0024-5MG
| InVivoMab anti-mouse CD80 (B7-1)
| 5 mg
| BioXCell
| In vivo CD80 blockade, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0072-5MG
| InVivoMab anti-mouse T15 VH and T15 VL regions of IgM
| 5 mg
| BioXCell
| ELISA
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0043-50MG
| InVivoMab anti-mouse IL-2
| 50 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0005-1-1MG
| InVivoMab anti-mouse LFA-1? (CD11a)
| 1 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0014-50MG
| InVivoMab anti-human CD25 (IL-2R?)
| 50 mg
| BioXCell
| in vivo regulatory T cell depletion in humanized m
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0020-2-50MG
| InVivoMab anti-human CD54 (ICAM-1)
| 50 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, Immunofluo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0003-2-5MG
| InVivoMab anti-human CD4
| 5 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, in vivo CD
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0025-1MG
| InVivoMab anti-mouse CD86 (B7-2)
| 1 mg
| BioXCell
| In vivo CD86 blockade, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0000-1MG
| InVivoMab anti-mouse CD1d (CD1.1)
| 1 mg
| BioXCell
| in vivo CD1d neutralization, in vitro CD1d neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0012-50MG
| InVivoMab anti-mouse CD25 (IL-2R?)
| 50 mg
| BioXCell
| in vivo regulatory T cell depletion, Flow cytometr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0075-1-50MG
| InVivoMab anti-mouse Ly6G
| 50 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0015-1-1MG
| InVivoMab anti-mouse CD28
| 1 mg
| BioXCell
| in vitro T cell stimulatioN/Activation, in vivo CD
|
| Syrian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0034-1MG
| InVivoMab anti-mouse LPAM-1 (Integrin ?4?7)
| 1 mg
| BioXCell
| in vivo Integrin ?4?7 neutralization, Flow cytomet
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0029-50MG
| InVivoMab anti-mouse IFN?R (CD119)
| 50 mg
| BioXCell
| in vivo IFN?R neutralization, in vitro IFN?R neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0083-100MG
| InVivoMab mouse IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
BE0035-1MG
| InVivoMab anti-mouse MAdCAM-1
| 1 mg
| BioXCell
| in vivo MAdCAM-1 neutralization, Immunofluorescenc
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0068-1MG
| InVivoMab anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7)
| 1 mg
| BioXCell
| in vitro MHC class II I-A blocking, in vitro MHC c
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0076-1MG
| InVivoMab anti-mouse Thy1 (CD90)
| 1 mg
| BioXCell
| in vitro T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0002-100MG
| InVivoMab anti-mouse CD3
| 100 mg
| BioXCell
| in vitro T cell stimulatioN/Activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0033-2-50MG
| InVivoMab anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0086-1MG
| InVivoMab mouse IgG2b isotype control
| 1 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
BE0049-5MG
| InVivoMab anti-mouse IL-10
| 5 mg
| BioXCell
| in vivo IL-10 neutralization, in vitro IL-10 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0036-1MG
| InVivoMab anti-mouse NK1.1
| 1 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0063-25MG
| InVivoMab anti-mouse GITR
| 25 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0027-1MG
| InVivoMab anti-mouse CD106 (VCAM-1)
| 1 mg
| BioXCell
| in vivoVCAM-1 neutralization, Immunofluorescence
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0070-50MG
| InVivoMab anti-mouse TCR ?/?
| 50 mg
| BioXCell
| in vivo TCR ?/? neutralization, in vitro ?/? T cel
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0005-1-5MG
| InVivoMab anti-mouse LFA-1? (CD11a)
| 5 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0085-5MG
| InVivoMab mouse IgG2a isotype control
| 5 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
BE0052-50MG
| InVivoMab anti-mouse IL-12
| 50 mg
| BioXCell
| in vivo IL-12 neutralization, in vitro IL-12 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|